Login / Signup
Michael Dolton
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 7
Top Topics
Structural Basis
Magnetic Resonance Imaging
Transcription Factor
Adverse Drug
Top Venues
CPT: pharmacometrics & systems pharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
13 (4) (2024)
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
13 (4) (2024)
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
13 (4) (2024)
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
13 (4) (2024)
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
13 (4) (2024)
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
13 (4) (2024)
Christine Bowman
,
Michael Dolton
,
Fang Ma
,
Sravanthi Cheeti
,
Denison Kuruvilla
,
Rucha Sane
,
Nastya Kassir
,
Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.
CPT: pharmacometrics & systems pharmacology
(2024)